Showing results (11-20 of 30) with videos related to
Sort By:
Pageof 3
Laboratory Investigation; a Journal of Technical Methods and Pathology|May 1, 1997
Interleukin-10 is a mesangial cell growth factor in vitro and in vivoS J Chadban, G H Tesch, R Foti, et al.Journal of the American Society of Nephrology : JASN|May 1, 1995
Deoxyspergualin inhibits mesangial cell proliferation and major histocompatibility complex class II expressionD J Nikolic-Paterson, G H Tesch, H Y Lan, et al.Kidney International|June 1, 1997
Effect of interleukin-10 treatment on crescentic glomerulonephritis in ratsS J Chadban, G H Tesch, H Y Lan, et al.The Journal of Clinical Investigation|January 12, 1999
Monocyte chemoattractant protein-1 promotes macrophage-mediated tubular injury, but not glomerular injury, in nephrotoxic serum nephritisG H Tesch, A Schwarting, K Kinoshita, et al.Kidney International|September 29, 2001
LF15-0195 prevents the induction and inhibits the progression of rat anti-GBM diseaseG H Tesch, P A Hill, M Wei, et al.Journal of the American Society of Nephrology : JASN|July 1, 1996
De novo CD44 expression by proliferating mesangial cells in rat anti-Thy-1 nephritisD J Nikolic-Paterson, Z Jun, G H Tesch, et al.Diabetologia|July 3, 2004
Abnormal p38 mitogen-activated protein kinase signalling in human and experimental diabetic nephropathyL Adhikary, F Chow, D J Nikolic-Paterson, et al.Kidney International|December 24, 2005
Monocyte chemoattractant protein-1 promotes the development of diabetic renal injury in streptozotocin-treated miceF Y Chow, D J Nikolic-Paterson, E Ozols, et al.Diabetologia|December 13, 2006
Monocyte chemoattractant protein-1-induced tissue inflammation is critical for the development of renal injury but not type 2 diabetes in obese db/db miceF Y Chow, D J Nikolic-Paterson, F Y Ma, et al.Immunology|August 26, 1998
Interleukin-10 differentially modulates MHC class II expression by mesangial cells and macrophages in vitro and in vivoS J Chadban, G H Tesch, R Foti, et al.Pageof 3